Video

ONC-CHAT: 'VOGL, NEW YORK' on 10 Years of Tamoxifen


 

"VOGL, NEW YORK" is how Dr. Steven Vogl identifies himself when he stands up at major oncology meetings. He is by now well known for his pointed questions, and received a plaque at the 2010 San Antonio Breast Cancer Symposium in recognition of his unique contribution. Here is his take on a major study presented in 2012.

Recommended Reading

San Antonio Roundtable, Part 1: Fulvestrant Dose and Tamoxifen Duration
Breast Cancer ICYMI
Experimental Drug Puts ER-Positive Breast Cancer on Hold
Breast Cancer ICYMI
Less Invasive Biopsy Used Less in Black Breast Cancer Patients
Breast Cancer ICYMI
Doubling Fulvestrant Dose Extends Breast Cancer Survival
Breast Cancer ICYMI
Ten Years of Adjuvant Tamoxifen Found Superior to Five
Breast Cancer ICYMI
Bevacizumab Adds No Progression, Survival Benefits to Estrogen Therapy
Breast Cancer ICYMI
Mammograms Dip in Wake of USPSTF Recommendations
Breast Cancer ICYMI
San Antonio Roundtable, Part 2: CALOR Trial, Triple-Negative Breast Cancer
Breast Cancer ICYMI
PET/CT Pinpoints Physiological Evidence of Chemo Brain
Breast Cancer ICYMI
ONC-CHAT - What Did You Learn at the Meeting Today?
Breast Cancer ICYMI